GLP-1 medication and weight loss: Barriers and motivators among 1659 participants managed in a virtual setting.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- GLP-1 medication and weight loss: Barriers and motivators among 1659 participants managed in a virtual setting.
- Published In:
- Diabetes, obesity & metabolism, 27(7), 3780-3788 (2025)
- Authors:
- Naveed, Maneeha, Perez, Cecilie, Ahmad, Ehtasham, Russell, Laura, Lees, Zoe, Maybury, Catriona
- Database ID:
- RPEP-12741
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-12741APA
Naveed, Maneeha; Perez, Cecilie; Ahmad, Ehtasham; Russell, Laura; Lees, Zoe; Maybury, Catriona. (2025). GLP-1 medication and weight loss: Barriers and motivators among 1659 participants managed in a virtual setting.. Diabetes, obesity & metabolism, 27(7), 3780-3788. https://doi.org/10.1111/dom.16405
MLA
Naveed, Maneeha, et al. "GLP-1 medication and weight loss: Barriers and motivators among 1659 participants managed in a virtual setting.." Diabetes, 2025. https://doi.org/10.1111/dom.16405
RethinkPeptides
RethinkPeptides Research Database. "GLP-1 medication and weight loss: Barriers and motivators am..." RPEP-12741. Retrieved from https://rethinkpeptides.com/research/naveed-2025-glp1-medication-and-weight
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.